ONCOSIL MEDICAL
2004 - OncoSilTM was originally developed as BrachySilTM. pSivida grants exclusive worldwide royalty-bearing license agreement with Enigma Therapeutics for the development of BrachySil All preclinical and early phase clinical work conducted under sponsorship of pSivida February 2013 - Enigma Therapeutics was acquired by NeuroDiscovery Ltd June 2013 - NeuroDiscovery Ltd changed its name to OncoSil Medical Ltd and focused on developing OncoSilTM OncoSil Medical Ltd is an ASX-listed Medical Device Biotechnology Company headquartered in Sydney, Australia with global representation
ONCOSIL MEDICAL
Industry:
Medical Device Therapeutics
Address:
North Sydney, New South Wales, Australia
Country:
Australia
Status:
Active
Contact:
+61 2 9223 3344
Email Addresses:
[email protected]
Similar Organizations
Noctrix Health
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Current Employees Featured
More informations about "OncoSil Medical"
Patients - OncoSil
David joined OncoSil Medical in 2015 and comes with over 25 years’ experience in this field. Prior to joining OncoSil, David ran his own consulting firm specialising in the medical device, …See details»
OncoSil Medical - Crunchbase Company Profile & Funding
- NeuroDiscovery Ltd changed its name to OncoSil Medical Ltd and focused on developing OncoSilTM OncoSil Medical Ltd is an ASX-listed Medical Device Biotechnology Company …See details»
A patient’s guide OncoSil
The safety of OncoSilâ„¢ has not been established in children being breastfed by patients at the time of implantation or subsequent to implantation. Therefore, it is recommended that patients …See details»
An Introduction to OncoSil™ for - ORGANIZATION OF …
Organization of Agreement States August 20, 2019 An Introduction to OncoSilâ„¢ for Treating Cholangiocarcinoma and Pancreatic Tumors ... •OncoSil Medical Ltd. is a small medical …See details»
2022 Annual Report - OncoSil
On behalf of the Board, I welcome all new and existing shareholders to OncoSil Medical’s 2021-2022 Annual Report. Despite being adversely impacted by COVID-19 headwinds during the …See details»
OncoSil Medical (ASX:OSL) Company Profile & Description - Stock …
Mar 24, 2025 Its lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based …See details»
Pancreatic Cancer Treatment: OncoSilâ„¢ | Open Medscience
Summary: OncoSilâ„¢ is a Phosphorus-32 Loaded Microparticle designed to deliver targeted brachytherapy directly into pancreatic tumours.In April 2020, it received European CE marking …See details»
OncoSil Medical Ltd: A Comprehensive Company …
Nov 4, 2023 OncoSil Medical Ltd (OSL.AX) is a publicly traded medical device company making significant strides in the fight against cancer. Listed on the Australian Stock Exchange (ASX), this innovative ...See details»
Innovative Avenue of Treatment – Internal Radiotherapy for Locally ...
Jun 4, 2024 OncoSil Medical is a medical technology company that aims to improve the treatment of patients with pancreatic cancer. The OncoSilâ„¢ device consists of microparticles containing Phosphorous-32 ( 32 P) which are delivered by injection directly into a patient’s unresectable locally advanced pancreatic cancer tumour under endoscopic ultrasound …See details»
Oncosil Medical Company Profile - Office Locations, Competitors …
Oct 4, 2024 OncoSil Medical (formerly NeuroDiscovery) is a medical device company focused on localized treatments for patients with pancreatic and liver cancer. It offers OncoSil System, …See details»
A Pilot Study of OncoSilâ„¢ Given to Patients With Pancreatic Cancer ...
(radiological) medical device OncoSilâ„¢, when implanted into patients with pancreatic. cancer, in conjunction with Standard chemotherapy. OncoSilâ„¢, is an experimental treatment. ... Lead …See details»
OncoSil’s Milestone: 200 Patients Treated Worldwide - Nasdaq
Jun 3, 2024 OncoSil Medical’s strategy to penetrate global markets continues to gain momentum as more patients are onboarded for treatment.For further insights into AU:OSL …See details»
Investors - OncoSil
David joined OncoSil Medical in 2015 and comes with over 25 years’ experience in this field. Prior to joining OncoSil, David ran his own consulting firm specialising in the medical device, …See details»
Organization: OncoSil Medical - Cbonds.com
OncoSil Medical. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»
OncoSil Medical Gains Key Approvals and Expands Reach
Oct 24, 2024 OncoSil Medical Limited has achieved a significant milestone with the German Federal Joint Committee’s approval for a trial of its pancreatic cancer treatment, which will be …See details»
Driven by a Noble Mission: OncoSil’s Commitment to Fighting …
Nov 5, 2023 Cancer is a formidable adversary, affecting millions of lives worldwide. In the battle against this complex disease, companies like OncoSil Medical Ltd (OSL.AX) are driven by a mission to make a…See details»
Hamid Bimesl - Physician Information - CPSO
OncoSilâ„¢ - EDH Nuclear Medicine & Healthcare Services
To treat patients with locally advanced unresectable pancreatic cancer (LAPC) OncoSilâ„¢, is a single-use brachytherapy (internal radiation) device used to deliver a pre-determined dose of …See details»
Revolutionizing Cancer Treatment with Oncosil: A Beacon of Hope
Oct 16, 2023 Oncosil, a groundbreaking medical solution, is leading the way in the fight against pancreatic cancer, a disease that has long presented a significant challenge to the medical community.See details»
List of Ontario Non-Profit Corporations Finally Released
A canadian hope for hopeless humanity organization a cappella niagara inc. a cappella showcase a celebration of women foundation inc. a chance animal rescue inc. a child's dream of hope foundation a child's secret garden daycare inc. a child's world family child care services of niagara a christian connection niagara inc.See details»